Business
iOS
AndroidMore Episodes
Tax Matters: Spring Budget 2024 – The Hunt for Blue October
2024-03-07
859
No Worse Off #1: Overview of current restructuring trends
2024-03-05
1.5k
Essential Antitrust #38: What businesses can expect from China’s revised merger control regime
2024-02-08
871
Impressions from the J.P. Morgan Healthcare Conference – A MedTech Perspective
2024-02-01
695
Essential Antitrust #37: Antitrust in 2024: competition enforcement takes center stage
2024-01-18
1.6k
Legends of Tech #1: Turing with Vint and Whit: Boris Feldman in conversation with Vinton G. Cerf and Whitfield Diffie
2024-01-12
1.4k
Essential Antitrust Asia #9: updates with ABNR on antitrust in Indonesia
2024-01-10
499
Managing Risk in Asia #8: Opportunities for Asian and US investors post-US Executive Order on outbound investments
2023-12-28
653
Tax Matters: Trends in tax disputes – what should businesses be aware of?
2023-12-13
656
Essential Antitrust #36: The UK’s Digital Markets, Competition and Consumers Bill – what you need to know
2023-12-08
1.1k
Essential Antitrust #35: Gender Inclusive Antitrust Toolkit: a new lens for policy and enforcement
2023-11-29
752
Tax Matters: Autumn Statement 2023 – tax cuts in the NIC of time?
2023-11-23
686
How secondaries have become primary to GPs and LPs
2023-11-17
892
From chaos to control: making the case for legal project managers
2023-11-16
726
Essential Antitrust #34: Olivier Guersent on competition enforcement: current trends
2023-10-18
1.6k
Essential Antitrust #33: Antitrust insights in Asia: navigating complex regulations and investment challenges
2023-09-18
1.1k
MedTech Across Borders – Recent Developments in Japan and the US
2023-09-06
841
MedTech x Creating System Change – Reducing clinician burnout, effectively using AI and more
2023-08-01
1.1k
Essential Antitrust #32: New US HSR Rules and Merger Guidelines: key takeaways
2023-07-26
1.3k
Managing risk in Asia #7: Managing licensing and collaboration risks in the life sciences arena in Asia
2023-07-24
952
